MARA While Bitcoin Falls: AI Pivot Drives Stock Surge
Marathon Digital climbs as Bitcoin slides, buoyed by a strategic pivot into enterprise AI compute infrastructure and ...
What To Include In A Financial Plan
Creating a financial plan? Learn what to include to ensure your success and financial stability for the future.
23,717 articles
Lucid Will Continue Historic Gains, Yet Watchful Investors
Lucid has built a reputation for rapid delivery gains, echoing early EV winners. This deep dive explains why the stoc...
Portfolio Manager Reveals Selling Lesson That Lasted
A veteran portfolio manager recounts selling a 19-bagger too early and explains how that misstep reshaped his long-te...
Treasury Demands Binance Comply with New Monitoring Rules
Regulators press Binance to bolster anti-money-laundering controls as new findings tie more than $1 billion to Iran-l...
CryptoQuant Says Bitcoin Profit-Taking Could Rise Further
Bitcoin profit-taking is picking up as the bear-market rally continues. CryptoQuant reports rising on-chain profits a...
There Odds That Dogecoin Closes May Below $0.10 Here’s Why
Dogecoin trades near a key support at $0.10 as market bets pile up that the meme coin will close May below that level...
Celsius: From Highs, Stock - Is It a Buy Right Now?
Celsius shares have fallen more than 50% from their intraday peaks as growth from newly acquired brands accelerates. ...
Ethereum Price Analysis: Must Reclaim Key Level Now
Ethereum sits around $2,150, facing a pivotal $2,400 hurdle. In ethereum price analysis: must terms, a clear reclaim ...
ZachXBT Alleges Insider Control in LAB Token Inquiry
ZachXBT alleges insider control as LAB token scrutiny rises amid an investigation into AI Terminal's $6 billion FDV p...
Bitwise Launch Hyperliquid (HYPE) ETF Moves to NYSE
Bitwise is set to list BHYP, a new ETF tracking Hyperliquid's HYPE token, on the NYSE. The move aims to give traditio...
Battle Listings: Brokerages Reclaiming Data Control
Brokerages are reclaiming control over listing data as portals monetize information. The shift reshapes lending, pric...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status